All NKCEs generated in the study demonstrated the ability to eliminate EGFR-expressing cancer cells; however, the potency and efficacy of tumor cell killing varied significantly depending on the specific epitopes on NKp30 that each NKCE targeted. This evidence concerns the gene NCR3 and neoplasm.